Can We Identify Patients with High Risk of Osteoarthritis Progression Who Will Respond to Treatment? A Focus on Biomarkers and Frailty
ContributorsArden, Nigel; Richette, Pascal; Cooper, Cyrus; Bruyère, Olivier; Abadie, Eric; Branco, Jaime; Brandi, Maria Luisa; Berenbaum, Francis; Clerc, Cécile; Dennison, Elaine; Devogelaer, Jean-Pierre; Hochberg, Marc; D'Hooghe, Pieter; Herrero-Beaumont, Gabriel; Kanis, John A.; Laslop, Andrea; Leblanc, Véronique; Maggi, Stefania; Mautone, Giuseppe; Pelletier, Jean-Pierre; Petit-Dop, Florence; Reiter-Niesert, Susanne; Rizzoli, René; Rovati, Lucio; Tajana Messi, Eleonora; Tsouderos, Yannis; Martel-Pelletier, Johanne; Reginster, Jean-Yves
Published inDrugs & aging, vol. 32, no. 7, p. 525-535
Publication date2015
Affiliation entities
Research groups
Citation (ISO format)
ARDEN, Nigel et al. Can We Identify Patients with High Risk of Osteoarthritis Progression Who Will Respond to Treatment? A Focus on Biomarkers and Frailty. In: Drugs & aging, 2015, vol. 32, n° 7, p. 525–535. doi: 10.1007/s40266-015-0276-7
Main files (1)
Article (Published version)
Identifiers
- PID : unige:75896
- DOI : 10.1007/s40266-015-0276-7
- PMID : 26085027
Additional URL for this publicationhttp://link.springer.com/10.1007/s40266-015-0276-7
Journal ISSN1170-229X